Genome-wide methylation analysis identifies ELOVL5 as an epigenetic biomarker for the risk of type 2 diabetes mellitus.
Sci Rep
; 8(1): 14862, 2018 10 05.
Article
in En
| MEDLINE
| ID: mdl-30291282
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Acetyltransferases
/
DNA Methylation
/
Diabetes Mellitus, Type 2
Type of study:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Animals
/
Humans
/
Male
Language:
En
Journal:
Sci Rep
Year:
2018
Document type:
Article
Country of publication:
United kingdom